Sequential gemcitabine–docetaxel in BCG-naïve and BCG-failure non–muscle-invasive bladder cancer: a systematic review and meta-analysis - Poll - MDSpire

Sequential gemcitabine–docetaxel in BCG-naïve and BCG-failure non–muscle-invasive bladder cancer: a systematic review and meta-analysis

  • By

  • Bandar Alhubaishy

  • Ibrahim Beshawri

  • Inam Abulreish

  • Omar Alnajar

  • Hamad Radhi

  • Abduljawad Saleh

  • Saher Alwafi

  • Abdulghafour Halawani

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Sequential gemcitabine–docetaxel in BCG-naïve and BCG-failure non–muscle-invasive bladder cancer: a systematic review and meta-analysis

  • by Bandar Alhubaishy, Ibrahim Beshawri, Inam Abulreish, Omar Alnajar, Hamad Radhi, Abduljawad Saleh, Saher Alwafi, Abdulghafour Halawani

  • July 9, 2026

Related Content

The emerging roles of eosinophils in immune regulation in health and disease

Global burden and temporal trends of kidney cancer among children from 1990 to 2021: an analysis with projections to 2036

Systemic immune remodeling following curative (R0) resection of colorectal liver metastases